 TORONTO, Oct. 12, 2021 PRNewswire -- Field Trip Health Ltd. TSX: FTRP; FTRP.WT; Nasdaq: FTRP Field Trip, a leader in the development and delivery of psychedelic therapies, today announced that Joseph del Moral, Co-Founder CEO of Field Trip, will present at the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on Wednesday, October 13 th at 12:30pm ET. 